mibefradil has been researched along with Cardiovascular Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keil, U | 1 |
| Giles, TD | 1 |
| Abernethy, DR | 1 |
| Habib, G | 1 |
| Bullingham, R; Welker, HA; Wiltshire, H | 1 |
| Angus, JA; Wright, CE; Xi, Q | 1 |
3 review(s) available for mibefradil and Cardiovascular Diseases
| Article | Year |
|---|---|
Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonist.
Topics: Animals; Benzimidazoles; Binding Sites; Calcium Channel Blockers; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Coronary Vessels; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Heart Conduction System; Heart Rate; Hemodynamics; Humans; In Vitro Techniques; Mibefradil; Muscle, Smooth; Renal Circulation; Tetrahydronaphthalenes; Vascular Resistance | 1997 |
Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality.
Topics: Adrenergic beta-Antagonists; Benzimidazoles; Calcium Channel Blockers; Cardiovascular Diseases; Heart Rate; Humans; Hypertension; Mibefradil; Myocardial Infarction; Risk Factors; Tetrahydronaphthalenes | 1997 |
Clinical pharmacokinetics of mibefradil.
Topics: Benzimidazoles; Calcium Channel Blockers; Cardiovascular Diseases; Drug Interactions; Food-Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Mibefradil; Tetrahydronaphthalenes | 1998 |
3 other study(ies) available for mibefradil and Cardiovascular Diseases
| Article | Year |
|---|---|
[Progress in new cardiovascular treatment. Background discussion and interview in the Basel Roche Research Center].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiovascular Diseases; Cilazapril; Endothelins; Hemodynamics; Humans; Mibefradil; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
Topics: Absorption; Animals; Benzimidazoles; Biological Availability; Calcium Channel Blockers; Cardiovascular Diseases; Heart Rate; Humans; Liver; Mibefradil; Tetrahydronaphthalenes | 1997 |
Targetting voltage-gated calcium channels in cardiovascular therapy.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Mibefradil; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Terminology as Topic | 2000 |